Age and Sex Associate with Outcome in Older AML and High Risk MDS Patients Treated with 10-Day Decitabine

Investigators described the impact of performance status, comorbidity, and physical functioning on overall survival in 115 older patients treated on a clinical trial with a 10-day decitabine schedule.